59 results
P
I/C
l, o, w, -, l, e, v, e, l, , a, r, s, e, n, i, c, , (, A, s, ), , c, o, n, c, e, n, t, r, a, t, i, o, n, , i, n, , d, r, i, n, k, i, n, g, , w, a, t, e, r, d, r, i, n, k, i, n, g, , w, a, t, e, r, , A, s, , c, o, n, c, e, n, t, r, a, t, i, o, n, s, , l, o, w, e, r, , t, h, a, n, , t, h, e, , W, H, O, , p, r, o, v, i, s, i, o, n, a, l, , g, u, i, d, e, l, i, n, e, , v, a, l, u, e, , (, 1, 0, , µ, g, /, L, )
O
p, o, o, l, e, d, , a, s, s, o, c, i, a, t, i, o, n, , b, e, t, w, e, e, n, , t, h, e, , r, e, l, a, t, i, v, e, , r, i, s, k, , o, f, , e, a, c, h, , c, a, r, d, i, o, v, a, s, c, u, l, a, r, , d, i, s, e, a, s, e, , (, C, V, D, ), , e, n, d, p, o, i, n, t, , a, n, d, , l, o, w, -, l, e, v, e, l, , A, s, , c, o, n, c, e, n, t, r, a, t, i, o, n, , i, n, , d, r, i, n, k, i, n, g, , w, a, t, e, r
P
patients with localized infections
I/C
antibiotics formulated at concentrations between 0 and 6% w/w into bone cements, gentamycin-infused bone cement mixtures
O
eradication or delay of infection onset
P
patients with acute kidney injury, patients without acute kidney injury
I/C
suPAR levels, 5.23 ± 4.07 ng/mL vs. 3.23 ±0.67 ng/mL
O
association with the occurrence of AKI
P
adults
I/C
probiotics, no probiotics
O
VCAM-1 levels
P
COVID-19 patients
I/C
modern biomarkers, SARS-CoV-2 negative and positive patients
O
severity of illness, mortality
P
urticaria population, controls
I/C
Vitamin D supplementation, urticaria group vs. controls
O
mean difference of -9.35 ng/mL, association of urticaria with VitD deficiency, significant reduction in clinical urticarial score
P
patients
I/C
vitamin D2 supplementation, placebo or no intervention
O
serum vitamin D levels
P
men with negative prebiopsy prostate MRI or PI-RADS 3 or Likert 3 lesions
I/C
prostate-specific antigen density (PSAD), gold standard (biopsy pathology)
O
clinically significant prostate cancer (CSPCa)
P
asymptomatic pregnancies
I/C
quantitative fetal fibronectin (fFN) test, very high and very low risks of spontaneous preterm birth (sPTB)
O
delivery before 34 weeks, odds of sPTB prior to 28 weeks, odds of sPTB prior to 37 weeks
P
Chinese smokers
I/C
tobacco consumption, tobacco smoke, no tobacco consumption
O
exposure to nitrosamines, cancer risk